tirzepatide دواء جديد يخفض الوزن بنسبة ٢٢،٥٪؜ (ربع وزنك تقريبًا)! وافقت منذ أيام هيئة الغذاء والدواء الأمريكية على علاج جديد للسكر يخفض الوزن بصورة مذهلة، ربما تُغني عن جميع جراحات التخسيس في المستقبل Tirzepatide is a dual incretin

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4

AHK-Cu works through stimulation of dermal papilla cells, reduction of TGF-beta-1, upregulation of VEGF (which builds new vessels rather than widening existing ones), and inhibition of apoptosis

[8] Serious but uncommon events include acute myopia with secondary angle-closure glaucoma, typically emerging within the first two weeks of therapy

80 WangZ.LiX.ChaiS.LiW.LiS.HouM.et al (2023)

2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways